P38 MAP kinase inhibitors (WuXi AppTec)

N/A

Report date: 2025/03/20 09:29:54
NME

Base Information

Drug NameP38 MAP kinase inhibitors (WuXi AppTec)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP38 α mitogen-activated protein kinase inhibitors
TargetsP38 α mitogen-activated protein kinase
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWuxi Apptec Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Apptec Co Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A